This is a $349,282,851 firm fixed price delivery order awarded to Seqirus Inc., a division of the global biotechnology company CSL Seqirus, by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The task order provides services for H5 pandemic readiness, including the acquisition of medical countermeasures such as vaccines, adjuvants, and related products to combat influenza and other emerging infectious diseases. This award is issued under a $13.4 billion Indefinite Delivery Contract (IDC) previously awarded to Seqirus by HHS ASPR in February 2022. The contract does not have a set-aside designation. Seqirus operates a manufacturing facility in Holly Springs, North Carolina and has extensive experience providing critical medical countermeasures and services to support the federal government's pandemic preparedness and response efforts.
Generated 1/9/25, 9:26 AM